Streetbeat News

Stock Prices

TME

Tencent Music Entertainment's shares have seen an increase following the release of their Q1 earnings.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:14 am

ARM

Arm is reported to be launching AI chips in 2025, leading to an increase in its share prices.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:13 am

APGE

Apogee Therapeutics, Inc. (NASDAQ:APGE) reported advancements in clinical trials for treatments in inflammatory diseases, including atopic dermatitis, COPD, and asthma. The company highlighted the initiation of Phase 2 APG777 clinical trial, dosing of the first participant in APG808 Phase 1 trial, and selection of APG990 development candidate. Apogee also announced a completed $483 million upsized public offering and reported a net loss of $32.1M for the first quarter, with a cash position of $816.2M, expected to fund operations into Q1 2028.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:12 am

INCY

Incyte shares are trading higher following the company's approval of a $2 billion share buyback authorization.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:06 am

TCRX

TScan Therapeutics reported a Q1 2024 GAAP EPS of $(0.32), missing the $(0.26) estimate, and sales of $566,000, significantly below the $3.975M estimate.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:05 am

SQSP

Squarespace, Inc. (SQSP) has announced an agreement to go private in a $6.9 billion all-cash transaction with Permira, representing a 15% premium over its last closing share price.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:05 am

QBTS

D-Wave Quantum (QBTS) reported Q1 2024 earnings with a GAAP EPS of $(0.11), missing the $(0.10) estimate, and sales of $2.465M, below the $3.067M estimate. Despite these misses, both losses and sales showed significant improvement from the previous year, with losses decreasing by 45% and sales increasing by 55.72%.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:05 am

DTIL

Precision BioSciences (NASDAQ:DTIL) reported Q1 earnings of $1.70 per share, surpassing the $(1.91) estimate, marking a 124.64% increase from last year. Sales reached $17.58M, beating the $6.02M estimate, a 100.27% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:03 am

BITF

Bitfarms has announced the termination of CEO Geoffrey Morphy and is nearing the completion of its search for a new CEO. The company, which is listed on both the NASDAQ and TSX under the symbols BITF and TSX:BITF respectively, is in the process of leadership transition.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:02 am

LEGN

Legend Biotech (NASDAQ:LEGN) reported Q1 2024 earnings with a GAAP EPS of $(0.16), surpassing the $(0.34) estimate, indicating a significant improvement over the previous year. However, their sales of $93.991M fell short of the expected $152.631M, despite being a substantial increase from the previous year's $36.336M.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 11:02 am